Literature DB >> 18241799

Handling mammalian mitochondrial tRNAs and aminoacyl-tRNA synthetases for functional and structural characterization.

Marie Sissler1, Bernard Lorber, Marie Messmer, André Schaller, Joern Pütz, Catherine Florentz.   

Abstract

The mammalian mitochondrial (mt) genome codes for only 13 proteins, which are essential components in the process of oxidative phosphorylation of ADP into ATP. Synthesis of these proteins relies on a proper mt translation machinery. While 22 tRNAs and 2 rRNAs are also coded by the mt genome, all other factors including the set of aminoacyl-tRNA synthetases (aaRSs) are encoded in the nucleus and imported. Investigation of mammalian mt aminoacylation systems (and mt translation in general) gains more and more interest not only in regard of evolutionary considerations but also with respect to the growing number of diseases linked to mutations in the genes of either mt-tRNAs, synthetases or other factors. Here we report on methodological approaches for biochemical, functional, and structural characterization of human/mammalian mt-tRNAs and aaRSs. Procedures for preparation of native and in vitro transcribed tRNAs are accompanied by recommendations for specific handling of tRNAs incline to structural instability and chemical fragility. Large-scale preparation of mg amounts of highly soluble recombinant synthetases is a prerequisite for structural investigations that requires particular optimizations. Successful examples leading to crystallization of four mt-aaRSs and high-resolution structures are recalled and limitations discussed. Finally, the need for and the state-of-the-art in setting up an in vitro mt translation system are emphasized. Biochemical characterization of a subset of mammalian aminoacylation systems has already revealed a number of unprecedented peculiarities of interest for the study of evolution and forensic research. Further efforts in this field will certainly be rewarded by many exciting discoveries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241799     DOI: 10.1016/j.ymeth.2007.11.002

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

Review 1.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

2.  Crystal structures and biochemical analyses suggest a unique mechanism and role for human glycyl-tRNA synthetase in Ap4A homeostasis.

Authors:  Rey-Ting Guo; Yeeting E Chong; Min Guo; Xiang-Lei Yang
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

3.  Thermodynamic properties distinguish human mitochondrial aspartyl-tRNA synthetase from bacterial homolog with same 3D architecture.

Authors:  Anne Neuenfeldt; Bernard Lorber; Eric Ennifar; Agnès Gaudry; Claude Sauter; Marie Sissler; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

4.  Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).

Authors:  Grazyna Leszczynska; Piotr Leonczak; Karolina Wozniak; Andrzej Malkiewicz
Journal:  RNA       Date:  2014-04-22       Impact factor: 4.942

5.  Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier.

Authors:  Ana Martínez-Zamora; Salvador Meseguer; Juan M Esteve; Magda Villarroya; Carmen Aguado; J Antonio Enríquez; Erwin Knecht; M-Eugenia Armengod
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.